Department of Chemistry, National Tsing Hua University, Hsinchu 30043, Taiwan, ROC.
Biomaterials. 2010 Nov;31(32):8419-25. doi: 10.1016/j.biomaterials.2010.07.057. Epub 2010 Aug 10.
HeLa cells were incubated with neutron capture nuclei (boron-10 and gadolinium)-containing carbon nanoparticles, followed by irradiation of slow thermal neutron beam. Under a neutron flux of 6 x 10(11) n/cm(2) (or 10 min irradiation at a neutron flux of 1 x 10(9) n/cm(2) s), the percentages of acute cell death at 8 h after irradiation are 52, 55, and 28% for HeLa cells fed with BCo@CNPs, GdCo@CNPs, and Co@CNPs, respectively. The proliferation capability of the survived HeLa cells was also found to be significantly suppressed. At 48 h after neutron irradiation, the cell viability further decreases to 35 +/- 5% as compared to the control set receiving the same amount of neutron irradiation dose but in the absence of carbon nanoparticles. This work demonstrates "proof-of-concept" examples of neutron capture therapy using (10)B-, (157)Gd-, and (59)Co-containing carbon nanoparticles for effective destruction of cancer cells. It will also be reported the preparation and surface functionalization of boron or gadolinium doped core-shell cobalt/carbon nanoparticles (BCo@CNPs, GdCo@CNPs and Co@CNPs) using a modified DC pulsed arc discharge method, and their characterization by various spectroscopic measurements, including TEM, XRD, SQUID, FT-IR, etc. Tumor cell targeting ability was introduced by surface modification of these carbon nanoparticles with folate moieties.
将含中子俘获核(硼-10 和钆)的碳纳米粒子与 HeLa 细胞孵育,然后用慢热中子束照射。在 6 x 10(11) n/cm(2) 的中子通量下(或在 1 x 10(9) n/cm(2) s 的中子通量下照射 10 分钟),用 BCo@CNPs、GdCo@CNPs 和 Co@CNPs 喂养的 HeLa 细胞在照射后 8 小时的急性细胞死亡百分比分别为 52%、55%和 28%。还发现存活的 HeLa 细胞的增殖能力也受到明显抑制。在中子照射后 48 小时,与接受相同中子照射剂量但不含碳纳米粒子的对照组相比,细胞活力进一步降至 35 +/- 5%。这项工作证明了使用含(10)B、(157)Gd 和(59)Co 的碳纳米粒子进行中子俘获治疗的“概念验证”示例,可有效破坏癌细胞。还将报道使用改进的直流脉冲电弧放电方法制备和表面功能化硼或钆掺杂核壳钴/碳纳米粒子(BCo@CNPs、GdCo@CNPs 和 Co@CNPs)的情况,以及通过 TEM、XRD、SQUID、FT-IR 等各种光谱测量对其进行的表征。通过叶酸部分对这些碳纳米粒子进行表面修饰,引入了肿瘤细胞靶向能力。